Literature DB >> 15380814

Prostaglandin E2 receptor subtypes, EP1, EP2, EP3 and EP4 in human and mouse ocular tissues--a comparative immunohistochemical study.

Sumana Biswas1, Parimal Bhattacherjee, Christopher A Paterson.   

Abstract

The purpose of the present study was to compare the localization of prostaglandin E(2) receptor subtypes in normal human and mouse ocular tissues. Paraffin embedded sections of normal human and mouse (129 Sv/Ev) eyes were treated with EP(1), EP(2), EP(3) and EP(4) specific antibodies and subsequently incubated with Alexa Fluor secondary antibody (Ex/Em=555/571) to detect the presence of EP receptor proteins. Fluorescence of the localized antibodies was visualized in a Carl Zeiss Microscope (Axiovert 200) and photographed using Carl Zeiss Axiocam camera. In mice EP(1) and EP(3) receptor subtypes were only moderately expressed, EP(3) receptor expression being almost negligible. In human cornea and iris ciliary body, EP(1) and EP(3) receptors were prominently expressed. EP(4) receptor was expressed moderately in human and mouse ocular tissues. EP(2) receptor was the most prominently and abundantly expressed receptor in both human and mouse ocular tissues. It is concluded that the pattern of the distribution of EP receptor subtypes in the ocular tissues are similar in human and mouse. Thus, 129 Sv/Ev strains of mice would make an appropriate animal model for studying the ocular pathophysiological roles of prostaglandin receptor agonists.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380814     DOI: 10.1016/j.plefa.2004.03.021

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  15 in total

1.  Pharmacologic manipulation of conventional outflow facility in ex vivo mouse eyes.

Authors:  Alexandra Boussommier-Calleja; Jacques Bertrand; David F Woodward; C Ross Ethier; W Daniel Stamer; Darryl R Overby
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-24       Impact factor: 4.799

Review 2.  Prostanoid receptor agonists for glaucoma treatment.

Authors:  Makoto Aihara
Journal:  Jpn J Ophthalmol       Date:  2021-07-06       Impact factor: 2.447

3.  Expression of prostaglandin E2 receptor subtypes in human pterygium and normal conjunctiva: immunohistochemical study.

Authors:  Erdem Dinç; Özer Dursun; Banu Yılmaz; Mustafa Vatansever; A Ayça Sarı; Özlem Yıldırım; Ufuk Adıgüzel
Journal:  Int Ophthalmol       Date:  2017-07-10       Impact factor: 2.031

4.  Selective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesis.

Authors:  Elvira L Liclican; Van Nguyen; Aaron B Sullivan; Karsten Gronert
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-07-07       Impact factor: 4.799

Review 5.  Effects of Tafluprost on Ocular Blood Flow.

Authors:  Xinyue Zhang; Xiaoyu Zhou; Yang Zhao; Xiang Yang; Dengming Zhou; Baihua Chen; Xuanchu Duan
Journal:  Ophthalmol Ther       Date:  2022-09-15

6.  Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys.

Authors:  B'Ann True Gabelt; Elizabeth A Hennes; Mark A Bendel; Chase E Constant; Mehmet Okka; Paul L Kaufman
Journal:  J Ocul Pharmacol Ther       Date:  2009-02       Impact factor: 2.671

Review 7.  Prospects for lentiviral vector mediated prostaglandin F synthase gene delivery in monkey eyes in vivo.

Authors:  Eun Suk Lee; Carol A Rasmussen; Mark S Filla; Sarah R Slauson; Aaron W Kolb; Donna M Peters; Paul L Kaufman; B'Ann T Gabelt; Curtis R Brandt
Journal:  Curr Eye Res       Date:  2014-02-21       Impact factor: 2.424

Review 8.  Endocannabinoids in the retina: from marijuana to neuroprotection.

Authors:  Stephen Yazulla
Journal:  Prog Retin Eye Res       Date:  2008-08-03       Impact factor: 21.198

Review 9.  A multi-targeted approach to suppress tumor-promoting inflammation.

Authors:  Abbas K Samadi; Alan Bilsland; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Anupam Bishayee; Asfar S Azmi; Bal L Lokeshwar; Brendan Grue; Carolina Panis; Chandra S Boosani; Deepak Poudyal; Diana M Stafforini; Dipita Bhakta; Elena Niccolai; Gunjan Guha; H P Vasantha Rupasinghe; Hiromasa Fujii; Kanya Honoki; Kapil Mehta; Katia Aquilano; Leroy Lowe; Lorne J Hofseth; Luigi Ricciardiello; Maria Rosa Ciriolo; Neetu Singh; Richard L Whelan; Rupesh Chaturvedi; S Salman Ashraf; H M C Shantha Kumara; Somaira Nowsheen; Sulma I Mohammed; W Nicol Keith; William G Helferich; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-05-05       Impact factor: 15.707

10.  Non-steroidal anti-inflammatory drug delays corneal wound healing by reducing production of 12-hydroxyheptadecatrienoic acid, a ligand for leukotriene B4 receptor 2.

Authors:  Satoshi Iwamoto; Tomoaki Koga; Mai Ohba; Toshiaki Okuno; Masato Koike; Akira Murakami; Akira Matsuda; Takehiko Yokomizo
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.